13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001201001
Total reported value
$170.0M
$170.0M
40 檔
89.6%
As reported in its official Q2 2024 Form 13F filing, Harbourvest Partners LLC's tracked investment portfolio stood at $170.0M with 40 total positions.
During Q2 2024, Harbourvest Partners LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TOST | Toast Inc-class A | Stock-Tech | 31.32% | — | — | |
| 2 | W | Wayfair Inc- Class A | Stock-Consumer Disc | 29.81% | — | — | |
| 3 | HCP2EUR | Hashicorp Inc-cl A | Stock-Other | 12.05% | — | +220.98% | |
| 4 | YMM | Full Truck Alliance -spn Adr | Stock-Other | 4.10% | -3.31% | — | |
| 5 | OHI | Omega Healthcare Investors, Inc. | Stock-Real Estate | 3.87% | — | — | |
| 6 | HAPN | Happen Inc | Stock-Other | 2.31% | — | — | |
| 7 | PGNY | Progyny Inc | Stock-Other | 1.37% | — | — | |
| 8 | HSAI | Hesai Group | Stock-Other | 1.35% | — | — | |
| 9 | IBRX | Immunitybio Inc | Stock-Healthcare | 1.13% | — | — | |
| 10 | BE | Bloom Energy Corp- A | Stock-Industrials | 1.06% | — | — | |
| 11 | ACVA | Acv Auctions Inc-a | Stock-Other | 1.05% | — | -4.42% | |
| 12 | RLAY | Relay Therapeutics Inc | Stock-Other | 1.03% | — | — | |
| 13 | NARIUSD | Inari Medical Inc | Stock-Other | 0.99% | — | — | |
| 14 | ZUOUSD | Zuora Inc - Class A | Stock-Other | 0.87% | — | — | |
| 15 | DOCN | Digitalocean Holdings Inc | Stock-Tech | 0.82% | — | — | |
| 16 | OLOGBX | Olo Inc - Class A | Stock-Other | 0.80% | — | — | |
| 17 | DOCS | Doximity Inc-class A | Stock-Healthcare | 0.74% | — | — | |
| 18 | HNST | Honest Co Inc/the | Stock-Other | 0.74% | — | — | |
| 19 | AMPL | Amplitude Inc-class A | Stock-Other | 0.72% | — | — | |
| 20 | SONDQ | Sonder Holdings Inc | Stock-Other | 0.55% | — | — | |
| 21 | DIBS | 1stdibs.com Inc | Stock-Other | 0.48% | — | — | |
| 22 | IAS | Integral Ad Science Holding | Stock-Other | 0.47% | — | — | |
| 23 | COUR | Coursera Inc | Stock-Other | 0.40% | — | — | |
| 24 | AFRM | Affirm Holdings Inc | Stock-Financials | 0.37% | — | -39.94% | |
| 25 | U | Unity Software Inc | Stock-Tech | 0.30% | — | — | |
| 26 | PLRX | Pliant Therapeutics Inc | Stock-Other | 0.28% | — | — | |
| 27 | EB4 | Eventbrite Inc-class A | Stock-Other | 0.26% | — | — | |
| 28 | GTM | Zoominfo Technologies Inc | Stock-Tech | 0.26% | — | — | |
| 29 | ✓ | Neuehealth Inc | Stock-Other | 0.15% | — | — | |
| 30 | QS | Quantumscape CORP | Stock-Consumer Disc | 0.15% | — | — | |
| 31 | OPEN | Opendoor Technologies Inc | Stock-Real Estate | 0.05% | — | — | |
| 32 | IPSC | Century Therapeutics Inc | Stock-Other | 0.04% | -0.02% | — | |
| 33 | RPTX | Repare Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 34 | MCRB1EUR | Seres Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 35 | PACB | Pacific Biosciences Of Calif | Stock-Other | 0.02% | — | — | |
| 36 | ✓ | Rallybio CORP | Stock-Other | 0.02% | — | — | |
| 37 | PMVP | Pmv Pharmaceuticals Inc | Stock-Other | 0.01% | — | — | |
| 38 | NXTCEUR | Nextcure Inc | Stock-Other | 0.01% | — | — | |
| 39 | ✓ | Aligos Therapeutics Inc | Stock-Other | — | — | — | |
| 40 | ✓ | Astra Space Inc | Stock-Other | — | — | — |
According to official SEC Form 13F filings, Harbourvest Partners LLC reported a total U.S. public equity portfolio value of $170.0M across 40 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TOST, W, HCP2EUR) accounted for 89.6% of total reported equity market value during Q2 2024.
During Q2 2024, Harbourvest Partners LLC's top holdings by market value included TOST (31.3%)、W (29.8%)、HCP2EUR (12.1%). The largest single position, TOST, represented 31.3% of total portfolio value.
In Q2 2024, Harbourvest Partners LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.